Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
83.20
+5.12 (6.56%)
Jul 17, 2026, 4:00 PM EDT - Market closed
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $271.98 million as of July 17, 2026. Its market cap has increased by 1,067.30% in one year.
Market Cap
271.98M
Enterprise Value
220.01M
1-Year Change
1,067.30%
Ranking
Category
Stock Price
$83.20
ChartMarket Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has increased from $228.30M to $271.98M, an increase of 19.13%. That is a compound annual growth rate of 2.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 271.98M | 131.67% |
| Dec 31, 2025 | 117.40M | 353.28% |
| Dec 31, 2024 | 25.90M | -15.91% |
| Dec 29, 2023 | 30.80M | -70.81% |
| Dec 30, 2022 | 105.50M | -38.34% |
| Dec 31, 2021 | 171.10M | -24.02% |
| Dec 31, 2020 | 225.20M | -35.58% |
| Dec 31, 2019 | 349.60M | 206.94% |
| Dec 31, 2018 | 113.90M | -50.11% |
| Feb 1, 2018 | 228.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALX Oncology Holdings | 271.14M |
| MacroGenics | 270.78M |
| Surrozen | 254.44M |
| Cartesian Therapeutics | 250.62M |
| Entrada Therapeutics | 249.89M |
| ProQR Therapeutics | 243.43M |
| Adagene | 241.16M |
| Fulcrum Therapeutics | 235.22M |